The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells
Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death in women. Hormone receptor-positive breast cancer is usually subjected to hormone therapy, while triple-negative breast cancer is more formidable and poses a therapeutic challenge. Glucose transporters a...
Saved in:
Main Authors: | Yu-Liang Li (Author), Hao-Cheng Weng (Author), Jui-Ling Hsu (Author), Shu-Wha Lin (Author), Jih-Hwa Guh (Author), Lih-Ching Hsu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways
by: Hao-Cheng Weng, et al.
Published: (2022) -
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
by: Elizabeth H. Stover, et al.
Published: (2022) -
WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis
by: Ren-Shu Zhang, et al.
Published: (2022) -
The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
by: Hai-Ling Gao, et al.
Published: (2023) -
Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo
by: Zhao YY, et al.
Published: (2014)